Graphite Bio, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1288817,
    "name": "Graphite Bio, Inc.",
    "stock_name": "Graphite Bio, Inc.",
    "full_name": "Graphite Bio, Inc.",
    "name_url": "stocks-analysis/graphite-bio-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "27.90",
    "chg": 0.59,
    "chgp": "2.16%",
    "dir": 1,
    "prev_price": "27.31",
    "mcapval": "1,102.09",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US38870X1046",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "340.78 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/graphite-bio-inc-1288817-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Graphite Bio, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-graphite-bio-inc-technically-bullish-or-bearish-3548134",
        "imagepath": "",
        "date": "2025-09-20 20:10:26",
        "description": "As of 5 August 2025, the technical trend for Graphite Bio, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and Bollinger Bands are also indicating a bullish stance. Daily moving averages confirm a bullish trend, while the KST shows bullish momentum on both weekly and monthly time frames. The Dow Theory reflects a mildly bullish outlook on both weekly and monthly periods. Despite the lack of signals from the RSI, the overall technical indicators suggest a strong bullish position.\n\nIn terms of performance, the stock has outperformed the S&P 500 across multiple periods, with a year-to-date return of 44.41% compared to the S&P 500's 12.22%, and a one-year return of 93.91% versus 17.14%...."
      },
      {
        "title": "Is Graphite Bio, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-graphite-bio-inc-overvalued-or-undervalued-3544275",
        "imagepath": "",
        "date": "2025-09-20 18:42:12",
        "description": "As of 30 July 2025, the valuation grade for Graphite Bio, Inc. has moved from does not qualify to risky, indicating increased concerns about its financial health. The company appears to be overvalued given its significant negative metrics, including a price-to-book value of 4.58 and a return on equity of -24.86%. Additionally, the EV to EBITDA ratio stands at -11.54, highlighting the challenges in generating positive earnings.\n\nIn comparison to its peer, Stoke Therapeutics, Inc., which has a fair valuation with a P/E ratio of 22.96 and an EV to EBITDA of 21.50, Graphite Bio's ratios suggest a less favorable position in the market. Despite this, Graphite Bio has shown strong stock performance, with a year-to-date return of 44.41% compared to the S&P 500's 12.22%, and a one-year return of 93.91% versus the S&P 500's 17.14%. This strong performance may not be sustainable given the underlying financial metrics,..."
      }
    ],
    "total": 5,
    "sid": "1288817",
    "stock_news_url": "https://www.marketsmojo.com/news/graphite-bio-inc-1288817"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Graphite Bio, Inc. technically bullish or bearish?

2025-09-20 20:10:26

As of 5 August 2025, the technical trend for Graphite Bio, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and Bollinger Bands are also indicating a bullish stance. Daily moving averages confirm a bullish trend, while the KST shows bullish momentum on both weekly and monthly time frames. The Dow Theory reflects a mildly bullish outlook on both weekly and monthly periods. Despite the lack of signals from the RSI, the overall technical indicators suggest a strong bullish position. In terms of performance, the stock has outperformed the S&P 500 across multiple periods, with a year-to-date return of 44.41% compared to the S&P 500's 12.22%, and a one-year return of 93.91% versus 17.14%....

Is Graphite Bio, Inc. overvalued or undervalued?

2025-09-20 18:42:12

As of 30 July 2025, the valuation grade for Graphite Bio, Inc. has moved from does not qualify to risky, indicating increased concerns about its financial health. The company appears to be overvalued given its significant negative metrics, including a price-to-book value of 4.58 and a return on equity of -24.86%. Additionally, the EV to EBITDA ratio stands at -11.54, highlighting the challenges in generating positive earnings. In comparison to its peer, Stoke Therapeutics, Inc., which has a fair valuation with a P/E ratio of 22.96 and an EV to EBITDA of 21.50, Graphite Bio's ratios suggest a less favorable position in the market. Despite this, Graphite Bio has shown strong stock performance, with a year-to-date return of 44.41% compared to the S&P 500's 12.22%, and a one-year return of 93.91% versus the S&P 500's 17.14%. This strong performance may not be sustainable given the underlying financial metrics,...

View All News